Subscribe to
this category
r

Business

A total of 144 posts are filed under Business
Horizon Pharma plc Announces FDA Approval to Expand the Age Range for RAVICTI® to People with Urea Cycle Disorders Ages Two Months +
Horizon Pharma plc (NASDAQ:HZNP), a biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring… Continue Reading
Promising Week for Treatment of Form of Batten Disease: Approvals Granted by FDA and Europe’s CHMP
Significant progress was made last week for those suffering from Batten Disease (CLN2), a form of lysosomal storage disorder characterized… Continue Reading
BioPharma Dive: 5 Trends Shaping Rare Disease Drug Development
Story by Ned Pagliarulo Amid ongoing scrutiny of rising prescription drug costs, a three decade-old law has become a new flash point in the… Continue Reading
RDR: Cydan Announces Acquisition of Its Rare Disease Spin-out Vtesse
The orphan drug accelerator company, Cydan Development announces that Sucampo Pharmaceuticals Inc. has acquired Vtesse Inc. Cydan… Continue Reading
Teva Announces FDA Approval of AUSTEDO™ (deutetrabenazine) Tablets for the Treatment of Chorea Associated with Huntington’s Disease
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that the U.S. Food and Drug Administration (FDA) has approved… Continue Reading
PROQR
ProQR Appoints David M. Rodman, MD as Chief Development Strategy Officer
ProQR Therapeutics N.V. (Nasdaq: PRQR) today announced that it appointed David M. Rodman, MD as Chief Development Strategy Officer. Dr.… Continue Reading
Regenerative_Cell_Thera[y
InGeneron Completes Strategic Financing from Sanford Health to Advance Regenerative Cell Therapies
 InGeneron Inc., a regenerative medicine and cell therapy company, announces that Sanford Health, one of the largest integrated healthcare… Continue Reading
be-a-guest-blogger

Follow us on Twitter